AzTrials
AzTrials

Breast EngorgementBMCCLENCT07017894

Applying Breast Mask Containing Cabbage Leaves Extract to Relieve Breast Discomfort in Breastfeeding Women

A study testing Experimental: breast mask containing cabbage leaves extract group in people with Breast Engorgement, run by Taipei Veterans General Hospital, Taiwan at 1 site in Taiwan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

In this article, women were randomly assigned to the Breast Mask Containing Cabbage Leaves Extract group and Breast Mask without Cabbage Leaves Extract group, and the breast engorgement, pain, hardness, before and after each treatment were measured. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Breast Engorgement
What is being tested?
Experimental: breast mask containing cabbage leaves extract group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
154 participants
Where
1 siteTaiwan
Study dates
1 Jun 2025to 13 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Over 18 years old.
  • Breastfeeding.
  • Physiological breast swelling, breast heaviness, lumps, milk plugging, breast pain after childbirth.
  • Able to read and understand Chinese.

Who cannot join

  • Stillbirth
  • Allergy to cabbage or sulfa.
  • lactation inhibitors agents used.
  • Fever symptoms (> 38 degrees Celsius), including: wound infection, upper respiratory tract infection, urinary tract infection.
  • Breast symptoms, including: nipple cracks, skin damage, breast abscesses, mastitis, Malignant tumors.
  • Postpartum complications, including: postpartum hemorrhage, amniotic fluid embolism or other diseases requiring close care.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site
  • Taipei Veterans General Hospital

    Taipei, Beitou Dist, 112304

    Taipei Veterans General Hospital

Other trials in Taiwan

About this study

Official title: Applying Breast Mask Containing Cabbage Leaves Extract to Relieve Breast Discomfort in Breastfeeding Women:A Double-blind Randomized Controlled Trial

In this article, women were randomly assigned to the Breast Mask Containing Cabbage Leaves Extract group and Breast Mask without Cabbage Leaves Extract group, and the breast engorgement, pain, hardness, before and after each treatment were measured. At the end of the study breast mask user experience and continued breastfeeding were measured.

Read the detailed description

Breast engorgement as the swelling and distention of breast, which is one of the most common problems often occurs 2-4 days after delivery, resulting in pain and fever, which reduces the intention of mothers to continue breastfeeding and causes to stop breastfeeding in the early postpartum period.

There are many conservative treatments for relieving breast engorgement. At present, there have been published studies on the application of medications, cold compresses, warm compresses, massages, gua sha and cabbage leaves compression to breast problems during lactation. Previous studies have shown that cabbage leaves compression can relieve the breast engorgement, pain, and hardness of postpartum women. However, safety concerns related to freshness, preservation, and residual pesticides must be considered when using cabbage leaves in a clinical setting. The purpose of this study was to examine whether breast mask containing cabbage leaves extract can improve breast engorgement, pain, and hardness.

Being tested
Experimental: breast mask containing cabbage leaves extract group, Sham Comparator
Keywords
breast engorgement, pain, hardness
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental: breast mask containing cabbage leaves extract groupCombination product

    apply breast mask to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days

  • Sham ComparatorCombination product

    Apply a breast mask without cabbage leaves extract to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days.

Study groups in NCT07017894
Study groupRoleWhat they receive
breast mask containing cabbage leaves extract groupExperimentalApply the breast mask containing cabbage leaf extract to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days.
Receives: Combination Product: Experimental: breast mask containing cabbage leaves extract group
breast mask without cabbage leaves extract groupSham comparatorApply a breast mask without cabbage leaves extract to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days.
Receives: Combination Product: Sham Comparator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Breast engorgement_self-rating scale

    Total four items of breast engorgement, pain, hardness, and heat. There are eleven grades, a score of 0 represents no problem at all, and a score of 10 represents the most severe degree.

    Measured: Day1, 2, 3

  2. Breast hardness_Physiological measurements

    NEUTONE TDM-Z2 durometer pressure gauge

    Measured: Day1,2,3.

Secondary outcomes (2)
  1. Breast mask user experience

    Does Pleura fit your needs? Pleural comfort level? Purchase intention? Recommend others to buy? How much would you consider buying it at?

    Measured: Day 3

  2. Continued breastfeeding

    Total five items. There are five items of Exclusive breastfeeding/breastfeeding, Exclusive breastfeeding/bottle feeding, Exclusive breastfeeding/breastfeeding and bottle feeding, Mixed feeding, Feeding formula.

    Measured: Day 30

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2025
  2. Study start1 Jun 2025 (estimated)
  3. Primary completion1 Jul 2025 (estimated)
  4. Study completion13 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
two-group pre-test and repeated post-test study design
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
154 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07017894
Sponsor's protocol ID
2025-04-009A
Other IDs
ACIC-114-005
Acronym
BMCCLE
Status last verified
Jun 2025
First submitted
4 Jun 2025
Last updated
12 Jun 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Experimental: breast mask containing cabbage leaves extract group in people with Breast Engorgement, run by Taipei Veterans General Hospital, Taiwan at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Shu Chen Liao (+886228712121 ext. 82003, scliao@vghtpe.gov.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Breast engorgement_self-rating scale (time frame: Day1, 2, 3). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in